CFHR4 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test
Comprehensive Genetic Analysis for Kidney Health
The CFHR4 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for kidney-related disorders. This advanced test specifically targets the CFHR4 gene, which plays a critical role in regulating the complement system – a vital component of our immune defense mechanism. When mutations occur in this gene, it can lead to atypical hemolytic uremic syndrome (aHUS), a serious condition characterized by kidney failure, hemolytic anemia, and low platelet count.
What Does This Test Measure?
This comprehensive genetic analysis utilizes Next-Generation Sequencing (NGS) technology to examine the complete CFHR4 gene sequence for:
- Point mutations and single nucleotide variations
- Insertions and deletions within the gene structure
- Copy number variations affecting gene expression
- Regulatory region abnormalities
- Pathogenic variants associated with complement dysregulation
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Unexplained kidney failure or renal impairment
- Recurrent episodes of hemolytic anemia
- Persistent thrombocytopenia without clear cause
- Family history of hemolytic uremic syndrome
- Multiple family members with kidney disorders
- Children with atypical HUS presentations
- Patients with complement-mediated kidney diseases
- Individuals planning pregnancy with family history of renal conditions
Key Benefits of Genetic Testing
Undergoing the CFHR4 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test provides numerous advantages:
- Early Diagnosis: Identifies genetic predisposition before severe symptoms develop
- Personalized Treatment: Enables targeted therapies based on genetic profile
- Family Planning: Provides crucial information for genetic counseling
- Proactive Management: Allows for monitoring and preventive measures
- Accurate Prognosis: Helps predict disease progression and outcomes
- Cost-Effective Care: Reduces unnecessary treatments through precise diagnosis
Understanding Your Test Results
Your genetic test results will be thoroughly explained by our certified genetic counselors:
- Positive Result: Indicates the presence of CFHR4 gene mutation associated with aHUS risk
- Negative Result: Suggests no detected mutations in the CFHR4 gene
- Variant of Uncertain Significance: Requires additional family studies for interpretation
- Carrier Status: Identifies individuals who may pass the condition to offspring
All results include comprehensive genetic counseling to ensure complete understanding and appropriate next steps.
Test Pricing and Details
| Test Feature | Details |
|---|---|
| Test Name | CFHR4 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Nationwide Testing Availability
We have established testing centers across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures convenient access to advanced genetic testing regardless of your location.
Take Control of Your Genetic Health Today
Don’t wait for symptoms to escalate. Early genetic testing can provide life-changing insights into your kidney health and overall well-being. Our team of genetic specialists, nephrologists, and certified counselors are ready to support you through every step of the testing process.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your CFHR4 Gene Hemolytic Uremic Syndrome NGS Genetic DNA Test and take the first step toward proactive health management.
